Use of immunoregulatory antibodies in the treatment of neoplastic disorders

Details for Australian Patent Application No. 2002243718 (hide)

International Classifications

Event Publications

20 February 2003 Application Open to Public Inspection

Published as AU-B-2002243718

4 November 2004 Change of Name(s) of Applicant(s), Section 104

Idec Pharmaceuticals Corporation The name of the applicant has been changed to Biogen Idec Inc.

6 December 2007 Application Accepted

Published as AU-B-2002243718

3 April 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.